AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own CNO Financial Group, you need to believe its middle income retirement and insurance focus can keep translating into steady earnings, even as regulation and competition evolve. The higher 2026 operating EPS guidance supports the near term profitability catalyst, but does not remove key risks around regulatory change and interest rate sensitivity, so the big picture thesis still rests on execution rather than this single upgrade.
The recent update on share repurchases, with 1,300,000 shares bought back for US$60,000,000 in the latest quarter and about US$3,463,950,000 since 2011, ties directly into the near term catalyst of more efficient capital deployment and supports the upgraded earnings guidance by spreading profits over a smaller share base.
Yet investors should be aware that if interest rates fall or stay low for longer, CNO’s investment income and margins could...
Read the full narrative on CNO Financial Group (it's free!)
CNO Financial Group's narrative projects $4.4 billion revenue and $483.3 million earnings by 2029. This implies fairly flat yearly revenue growth and an earnings increase of about $237.8 million from $245.5 million today.
Uncover how CNO Financial Group's forecasts yield a $51.75 fair value, a 6% downside to its current price.
The single fair value estimate from the Simply Wall St Community sits at US$51.75, showing how one retail view prices CNO today. Readers should weigh this against the upgraded 2026 earnings guidance and consider how quickly that could change if regulatory or rate conditions shift, then compare it with other community perspectives.
Explore another fair value estimate on CNO Financial Group - why the stock might be worth 6% less than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com